These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2456038)

  • 1. [A new animal model for intravesical chemotherapy of bladder cancer].
    Yamashita T; Ito J
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2087-92. PubMed ID: 2456038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The biological properties and drug sensitivity of rat bladder cancer implanted into the subcutis and the bladder wall of rats].
    Yamashita T
    Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):78-82. PubMed ID: 2738443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse.
    Nativ O; Dalal E; Hidas G; Aronson M
    Int J Urol; 2006 Oct; 13(10):1344-6. PubMed ID: 17010016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy.
    Chang SG; Lee SJ; Huh JS; Lee JH
    Oncol Rep; 2001; 8(2):257-61. PubMed ID: 11182036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathological changes associated with topical chemotherapy of adriamycin for bladder cancer].
    Fujioka T; Ishii N; Chiba R
    Hinyokika Kiyo; 1983 Aug; 29(8):869-73. PubMed ID: 6675437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis of recurrence in superficial bladder carcinoma by intravesical chemotherapy--comparative study between instillation of combined double anticancer agents and single anticancer agent].
    Ikeda R; Chikazawa I; Kobayashi Y; Shiroma K; Nakade T; Suga K; Shiba N; Nakajima C; Moriyama M; Kawamura K; Miyazawa K; Tanaka T; Tsugawa R; Suzuki K; Sato H; Kikuyama A
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):509-14. PubMed ID: 10097748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GFP image analysis in the mouse orthotopic bladder cancer model.
    De Velasco MA; Tanaka M; Anai S; Tomioka A; Nishio K; Uemura H
    Oncol Rep; 2008 Sep; 20(3):543-7. PubMed ID: 18695904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylaxis of recurrence of superficial bladder tumor by intravesical chemotherapy].
    Ikeda R; Kawamura K; Yamaguchi C; Miyazawa K; Sasagawa M; Taniguchi T; Shiraiwa K; Suzuki K; Tsugawa T; Kudo T
    Hinyokika Kiyo; 1989 Jul; 35(7):1135-9. PubMed ID: 2478008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer.
    Blietz CE; Thode B; Hauses M; Pries R; Meyer AJ; Doehn C; Jocham D; Kausch I
    In Vivo; 2009; 23(1):13-9. PubMed ID: 19368119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravesical instillation of adriamycin and other antineoplastic agents].
    Matsumura Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):372-6. PubMed ID: 7184406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
    Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
    Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravesical instillation of antitumor drugs in the development of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumors in rats.
    Suzuki T; Imai K; Takezawa Y; Tsuji H; Yamanaka H; Suzuki K
    Hinyokika Kiyo; 1989 Feb; 35(2):247-51. PubMed ID: 2735235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor].
    Kobayashi M; Sugaya Y; Yuzawa M; Ochi M; Morita T; Kobayashi Y; Tokue A; Hara Y
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1771-4. PubMed ID: 9757205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor].
    Masuda H; Hirose J; Suzuki K; Tajima A; Aso Y
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical instillation of Adriamycin. A model for standardization of the chemotherapy.
    Eksborg S; Nilsson SO; Edsmyr F
    Eur Urol; 1980; 6(4):218-20. PubMed ID: 7389775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental studies on intravesical instillation of 4'-epi-adriamycin for the treatment of bladder cancer].
    Tsushima T
    Hinyokika Kiyo; 1985 Nov; 31(11):1945-56. PubMed ID: 3867286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.